This research is designed to investigate the influence of the recipient microenvironment on human haploidentical donor stem cells which mature to become functioning T lymphocytes. While evidence exists in mice and Xenopus for thymic """"""""education"""""""" of such cells to recognize recipient major histocompatibility complex (MHC) antigens as self, it is not yet known whether this is true for man. The overall goal of the proposed research is to study the ontogeny, competence, tolerance and self-recognition specificities of T cells from infants with severe combined immunodeficiency who have received haploidentical (half- matched) stem cells isolated by soy lectin agglutination and sheep erythrocyte rosetting from opposite sex parental donors.
The aims are: 1) to define the sequential appearance post- transplantation of blood cells with immature and mature lymphocyte surface antigens, using a panel of monoclonal antibodies and multiparameter cytofluorography, and of cells with evidence of rearranged T cell receptor (Ti) genes, using cDNA probes to human Ti alpha and beta chain genes and in situ hybridization, 2) to correlate the appearance of these with a range of in vivo and in vitro immune functions, 3) to establish the genetic origin of the various types of immune cells (T, B, NK and monocytes) by karyotyping, HLA typing or DNA sequence polymorphism analysis, 4) to define the self-recognition specificities of the genetically donor T cells in the patient through mixed leukocyte culture experiments, and 5) to define the major histocompatibility complex restriction pattern of antigen recognition by tetanus toxoid-specific, genetically donor helper T cell clones derived from the blood of such chimeras using Epstein- Barr virus transformed B cell lines from the relevant genetic sources as antigen-presenting cells. It is important to know whether the efficacy of such transplants is due to the fact that the genetically donor T cells share a common HLA haplotype with host B and antigen-presenting cells or is due to a change in the donor T cells as they mature in the recipient which enables them to see recipient HLA antigens as self. If the latter, such transplants could conceivably be successful from unrelated donors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI018613-10
Application #
3480976
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1982-02-01
Project End
1992-01-31
Budget Start
1991-02-01
Budget End
1992-01-31
Support Year
10
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Patel, D D; Gooding, M E; Parrott, R E et al. (2000) Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 342:1325-32
Buckley, R H; Schiff, S E; Schiff, R I et al. (1999) Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340:508-16
Puck, J M; Pepper, A E; Henthorn, P S et al. (1997) Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 89:1968-77
Buckley, R H; Schiff, R I; Schiff, S E et al. (1997) Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 130:378-87
Pepper, A E; Buckley, R H; Small, T N et al. (1995) Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency. Am J Hum Genet 57:564-71
Russell, S M; Tayebi, N; Nakajima, H et al. (1995) Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800
Buckley, R H (1994) Breakthroughs in the understanding and therapy of primary immunodeficiency. Pediatr Clin North Am 41:665-90
Buckley, R H; Schiff, S E; Schiff, R I et al. (1993) Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol 30:92-101;discussion 102-4
Ochs, H D; Buckley, R H; Kobayashi, R H et al. (1992) Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood 80:1163-71
Puck, J M; Krauss, C M; Puck, S M et al. (1990) Prenatal test for X-linked severe combined immunodeficiency by analysis of maternal X-chromosome inactivation and linkage analysis. N Engl J Med 322:1063-6

Showing the most recent 10 out of 23 publications